Tetracycline and Oxacillin Act Synergistically on Biofilms and Display Increased Efficacy In Vivo Against Staphylococcus aureus
Current Microbiology · 2024
DOI: 10.1007/s00284-024-03959-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Microbiology, 2024. Verfasst von Amy K Tooke und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Biosciences, University of Sheffield, Sheffield, S10 2TH, UK. Hauptthemen laut MEDLINE: Biofilms, Oxacillin, Staphylococcus aureus, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MRC, BBSRC, NIH HHS.
Abstract (Originalsprache)
Oxacillin (bactericidal) and tetracycline (bacteriostatic) are clinically relevant antibiotics that are routinely prescribed to treat Staphylococcus aureus infections but not conventionally used in combination. There is an urgent need for treatment regimens that can act upon biofilms during infection, associated with chronic infections on indwelling devices, as well as acute planktonic (systemic) infection. Here we show that in an in vitro model oxacillin and tetracycline act synergistically against S. aureus UAMS-1 biofilms, reducing the concentration of both antibiotics necessary to eradicate an established biofilm. Using an in vivo zebrafish larval infection model with S. aureus NewHG, they display improved bacterial clearance compared to each drug alone and can counteract a loss of host phagocytes, an important innate defence against S. aureus . In these cases, the bacteriostatic nature of tetracycline enhances rather than dampens the bactericidal action of oxacillin, although an exact mechanism remains to be elucidated. We suggest a dual therapy could be of clinical use against biofilm-forming S. aureus and has a potential use in patients with a compromised immune system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Biosciences, University of Sheffield, Sheffield, S10 2TH, UK.
- Microbes in Health and Disease Theme, Newcastle University Biosciences Institute, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.
- Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.
- The Bateson Centre, University of Sheffield, Western Bank, Sheffield, S10 2TH, UK.
- School of Medicine and Population Health, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK.
- School of Biosciences, University of Sheffield, Sheffield, S10 2TH, UK. s.foster@sheffield.ac.uk.
Förderung
- MRC
- BBSRC
- NIH HHS
- NIH
Zitieren
APA
Tooke, A. K., Hodges, R. E., Pyrah, J. F., Bayles, K. W., Renshaw, S. A., & Foster, S. J. (2024). Tetracycline and Oxacillin Act Synergistically on Biofilms and Display Increased Efficacy In Vivo Against Staphylococcus aureus. Current Microbiology. https://doi.org/10.1007/s00284-024-03959-4
Vancouver
Tooke AK, Hodges RE, Pyrah JF, Bayles KW, Renshaw SA, Foster SJ. Tetracycline and Oxacillin Act Synergistically on Biofilms and Display Increased Efficacy In Vivo Against Staphylococcus aureus. Current Microbiology. 2024. doi:10.1007/s00284-024-03959-4
BibTeX
@article{Tooke2024,
author = {Tooke, Amy K and Hodges, Rebecca E and Pyrah, Josie F and Bayles, Kenneth W and Renshaw, Stephen A and Foster, Simon J},
title = {Tetracycline and Oxacillin Act Synergistically on Biofilms and Display Increased Efficacy In Vivo Against Staphylococcus aureus},
journal = {Current Microbiology},
year = {2024},
doi = {10.1007/s00284-024-03959-4}
}
EUVIMED